The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and the C terminus appears to be required for this interaction.
The herpes simplex virus type 1 (HSV-1) immediate-early regulatory protein ICP27 is required for the inhibition of host cell splicing during viral infection and for the reorganization of antigens associated with the small nuclear ribonucleoprotein particles (snRNPs). To determine what effect ICP27 had on splicing proteins that might cause their redistribution, we looked at proteins that were immunoprecipitated with anti-Sm antisera. No significant changes were seen in the migration or amounts of several snRNP common and snRNP-specific proteins from infected cells labeled with [35S]methionine, suggesting that the synthesis of these proteins was not altered by viral infection. However, when cells were labeled with 32Pi, differences were seen in the phosphorylation of at least two proteins depending on whether ICP27 was expressed. One protein, which had an apparent molecular mass of about 85 kDa, was highly phosphorylated during wild-type HSV-1 infection but much less so during infection with an ICP27 null mutant. The other protein, which migrated at the position of the U1 70-kDa protein and was precipitated with U1-specific antiserum, was also more highly phosphorylated when ICP27 was expressed during infection. Furthermore, a phosphoprotein with an apparent molecular mass of 63 kDa was found to coimmunoprecipitate with anti-Sm antisera during wild-type HSV-1 infection. ICP27 has an apparent molecular mass of 63 kDa, and immunoblot analysis confirmed that ICP27 coimmunoprecipitated with snRNPs. Analysis of mutations throughout the ICP27 protein demonstrated that the region that was required for this interaction was the C terminus of the protein, which includes a cysteine-histidine-rich region that resembles a zinc-finger-like motif. These data suggest that ICP27 interacts with snRNPs during infection and that it fosters changes in the phosphorylation state of at least two proteins that immunoprecipitate with snRNPs, although these studies do not demonstrate whether it does so directly or indirectly.
Sandri-Goldin
R M
RM
Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine 92717-4025, USA.
Hibbard
M K
MK
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology* / Q000378:metabolism; D001483:Base Sequence; D002522:Chlorocebus aethiops; D018259:Herpesvirus 1, Human / Q000472:pathogenicity; D006801:Humans; D017874:Immediate-Early Proteins; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008969:Molecular Sequence Data; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D012097:Repressor Proteins / Q000737:chemistry / Q000276:immunology*; D017411:Ribonucleoproteins, Small Nuclear / Q000096:biosynthesis / Q000276:immunology* / Q000378:metabolism; D014709:Vero Cells; D014764:Viral Proteins / Q000737:chemistry / Q000276:immunology*; D055517:snRNP Core Proteins
D000596:Amino Acids; D001323:Autoantibodies; D001324:Autoantigens; C057120:ICP27 protein, human herpesvirus 1; D017874:Immediate-Early Proteins; D012097:Repressor Proteins; D017411:Ribonucleoproteins, Small Nuclear; D014764:Viral Proteins; D055517:snRNP Core Proteins